Key facts
- Farmakim Laboratory Materials’s last known valuation is $127.0M (May 2025).
- It has raised $27.0M; the latest was PE Growth/Expansion ($27.0M) in May 2025.
- Notable investors include Diplomatic Trade.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Farmakim Laboratory Materials
- ·The full record, as it builds
Funding rounds
No funding rounds for Farmakim Laboratory Materials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Farmakim Laboratory Materials
Provider of distribution services intended for quality control and infection prevention in regulated industries. The company offers state-of-the-art solutions with technical support, enabling laboratories, pharmaceutical, beverage, glass, and healthcare sectors to maintain high standards of safety and operational efficiency.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Esenler, Turkey
- Founded
- 1978
- Employees
- 10
- Website
- farmakim.com/
- Ownership
- Privately Held (backing)
Farmakim Laboratory Materials doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Farmakim Laboratory Materials shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Farmakim Laboratory Materials in its N-PORT filings yet. We sweep new filings monthly.